Convalo Health International, Corp.

Convalo Health International, Corp.

March 21, 2016 09:00 ET

Convalo Health International Publishes Updated Investor Presentation Ahead of Road Show by CEO

LOS ANGELES, CALIFORNIA--(Marketwired - March 21, 2016) -


Convalo Health International, Corp. (Convalo) (TSX VENTURE:CXV), a company servicing the addiction recovery industry in the US, today published an updated investor presentation on its newly revamped investor website:

The presentation can be found on the investor presentation tab.

Stampp Corbin, Chief Executive Officer of Convalo, will be meeting with institutional investors in early April in Toronto, Montreal, Calgary and Vancouver to highlight the growth plans of the company and financial projections for 2016.

"I look forward to meeting with our shareholders early next month," said Stampp Corbin, CEO of Convalo. "We started our business a little over a year ago and we have seen fantastic growth since our launch, building our business to over $30 million in annualized revenue this past quarter. Our new presentation lays out our plans in 2016 to increase our business from three to eight locations, as well as the expected positive financial impact of this plan on earnings per share."

About Convalo

Convalo serves the addiction rehabilitation market and is led by seasoned management with experience in US healthcare. In 2014, Convalo made its first acquisition of a small, local addiction rehabilitation center in Los Angeles. That business has operated under the brand name BLVD Centers ( in a luxury Hollywood, California location. Convalo has since opened several more in-patient and outpatient locations.

BLVD offers patients access to a wide range of services, including addictive and co-occurring disorders, helpful to the recovery process. In conjunction with the 12-Step approach, BLVD also offers supplemental insurance-reimbursed services catering to a variety of communities: gender specific, creatively-oriented, meditation/mindfulness, trauma and LGBT affirmative.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Information in this news release that is not current or historical factual information may constitute forward-looking information within the meaning of securities laws. Implicit in this information, particularly in respect of the future outlook of Convalo and anticipated events or results, are assumptions based on beliefs of Convalo's senior management as well as information currently available to it. While these assumptions were considered reasonable by Convalo at the time of preparation, they may prove to be incorrect. Readers are cautioned that actual results are subject to a number of risks and uncertainties, including the availability of funds and resources to pursue operations, decline of reimbursement rates, dependence on few payors, possible new drug discoveries, a novel business model, dependence on key suppliers, granting of permits and licenses in a highly regulated business, competition, difficulty integrating newly acquired businesses, low profit market segments as well as general economic, market and business conditions, and could differ materially from what is currently expected. These financial measures are intended to provide additional information to investors concerning Convalo's performance including the outcome of any litigation with Hollywood Detox.

Contact Information